Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,883.44
(
-0.01%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 77
Posts 4790
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Re: corpstrat post# 71561

Friday, 01/16/2009 7:21:20 AM

Friday, January 16, 2009 7:21:20 AM

Post# of 257268
it's clear that atacicept's trials need to be removed (or moved) from the ZGEN listing since it was fully out-licensed to Merck Serono last fall.

? I would suggest that any trial that stands to influence a company's revenue by 100's of millions of dollars is pertinent to that company. ?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today